International Flavors & Fragrances overview

International Flavors & Fragrances (IFF) has recently attracted attention after a mixed performance in its stock returns and financials, with modest annual revenue growth alongside a reported net income loss and varied total returns across different time horizons.

The US$71.15 share price sits above its levels three months ago, reflected in a 90 day share price return of 5.45%. However, the 1 year total shareholder return of a 6.78% decline points to weaker longer term momentum.

If IFF’s mixed performance has you thinking about diversification, this could be a useful moment to scan for other materials names through the Simply Wall St screener, starting with 8 top copper producer stocks

With IFF trading at US$71.15, alongside an indicated intrinsic discount of about 40% and a discount to analyst price targets, the key question is whether this reflects a genuine margin of safety or whether the market is already pricing in future growth.

Most Popular Narrative: 21.6% Undervalued

With IFF last closing at US$71.15 against a narrative fair value of US$90.71, the widely followed storyline paints a picture of meaningful upside based on future cash flows, margins and capital allocation.

Recent divestitures of commodity businesses (e.g., Pharma Solutions, Soy Crush, Concentrates, Lecithin) and the ongoing strategic evaluation of the Food Ingredients segment are increasing IFF's focus on differentiated, higher-margin, innovation-driven products, supporting future margin expansion and higher earnings quality. Ongoing investments in R&D and capacity (especially in Health & Biosciences, Taste, and Specialty Fragrance Ingredients) are strengthening the company's innovation pipeline; management expects these initiatives to accelerate revenue and profit growth beginning in 2026 and reaching full impact by 2027.

Curious what sits underneath that higher fair value? The narrative leans heavily on a sharp earnings swing, richer margins and a premium profit multiple. It is useful to consider how those threads might connect over the next few years and how they fit with an almost 8% discount rate.

Result: Fair Value of US$90.71 (UNDERVALUED)

However, this upside story still depends on softer demand in key markets and on pressure on fragrance ingredients easing enough for margins to move closer to analyst assumptions.

Another way to look at IFF’s value

So far, the story leans heavily on future cash flows pointing to an undervalued stock, with IFF trading at a 39.6% discount to an estimated fair value of US$117.72 using the SWS DCF model. That is a wide gap, which raises a simple question: is the model too cautious or is the market too skeptical?

Next Steps

If the mixed signals so far leave you unsure, now is a good time to review the details yourself and weigh both the concerns and potential upside before the next move. You can start with the 3 key rewards and 1 important warning sign

Looking for more investment ideas?

If you are weighing what to do next with IFF, it makes sense to line it up against other potential ideas before making your move.

• Spot potential mispricings by scanning 61 high quality undervalued stocks that combine quality fundamentals with attractive entry points.
• Strengthen your income stream by reviewing 12 dividend fortresses that focus on higher yielding, resilient payers.
• Reduce portfolio stress by checking 69 resilient stocks with low risk scores built around resilient businesses with lower risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.